Wed, September 20, 2023
Tue, September 19, 2023
Mon, September 18, 2023
Fri, September 15, 2023
Thu, September 14, 2023
Wed, September 13, 2023

Robyn Karnauskas Reiterated (BMRN) at Strong Buy and Held Target at $140 on, Sep 15th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-140-on-sep-15th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Robyn Karnauskas of Truist Securities, Reiterated "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy and Held Target at $140 on, Sep 15th, 2023.

Robyn has made no other calls on BMRN in the last 4 months.



There are 13 other peers that have a rating on BMRN. Out of the 13 peers that are also analyzing BMRN, 5 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $100 on, Wednesday, September 13th, 2023
  • Andreas Argyrides of "Wedbush" Maintained at Hold with Decreased Target to $70 on, Tuesday, August 1st, 2023
  • George Farmer of "Scotiabank" Initiated at Hold and Held Target at $95 on, Thursday, July 27th, 2023
  • Whitney Ijem of "Canaccord Genuity" Maintained at Hold with Decreased Target to $104 on, Monday, July 3rd, 2023
  • David Lebowitz of "Citigroup" Maintained at Hold with Decreased Target to $96 on, Friday, June 30th, 2023


These are the ratings of the 8 analyists that currently disagree with Robyn


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $120 on, Thursday, September 14th, 2023
  • Debjit Chattopadhyay of "Guggenheim" Reiterated at Strong Buy and Held Target at $110 on, Wednesday, September 13th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $125 on, Tuesday, August 1st, 2023
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $108 on, Tuesday, August 1st, 2023
  • Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $185 on, Friday, July 21st, 2023
  • Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Held Target at $102 on, Wednesday, July 5th, 2023
  • Joel Beatty of "Baird" Reiterated at Buy and Held Target at $127 on, Friday, June 30th, 2023
  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $120 on, Wednesday, June 14th, 2023

Publication Contributing Sources